Cargando…
Evaluated outcomes in patients with Chronic Hepatitis C
AIM: The objective of this study was to evaluate the real outcomes of chronic hepatitis C patients, who treated with interferon plus ribavirin (INF-RBV) and peg-interferon plus ribavirin (PEG-RBV). BACKGROUND: Despite the PEG-RBV has become a standard treatment of hepatitis C virus (HCV) around the...
Autores principales: | Ashtari, Sara, Vahedi, Mohsen, Amin Pourhoseingholi, Mohammad, Reza Zali, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Institute for Gastroenterology and Liver Diseases
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017542/ https://www.ncbi.nlm.nih.gov/pubmed/24834289 |
Ejemplares similares
-
Estimation of average diagnosis and treatment costs of hepatitis C
por: Ashtari, Sara, et al.
Publicado: (2012) -
Annual Registry for Hepatitis C and Hepatitis B is Needed for Predicting the Burden of Hepatocellolar Carcinoma in Iran
por: Fazeli, Zeinab, et al.
Publicado: (2013) -
Direct Medical Care Costs Associated With Patients Diagnosed With Chronic HCV
por: Ashtari, Sara, et al.
Publicado: (2013) -
Estimation of Diagnosis and Treatment Costs of Non-Alcoholic Fatty Liver Disease: A Two-Year Observation
por: Ghamar Chehreh, Mohammad Ebrahim, et al.
Publicado: (2013) -
Trend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces
por: Hajizadeh, Nastaran, et al.
Publicado: (2017)